Moderna Chief Legal Officer Klinger Shannon Thyme exercised Options for 11,797 shares on September 4, 2026. The records also show 5,704 shares forfeited at $148.87 per share, with reported holdings of 87,044 and later 81,340 shares, plus 106,179 derivative securities for investors tracking insider ownership.
Key Highlights
- Klinger Shannon Thyme forfeited 5,704 shares at $148.87 per share.
- Reported share ownership moved from 87,044 shares to 81,340 shares after separate transactions.
- The derivative-security balance stood at 106,179 after the option exercise.
Moderna, Inc. (NASDAQ: MRNA) Chief Legal Officer Klinger Shannon Thyme exercised options for 11,797 shares on September 4, 2026. The records list separate changes to the executive’s share and derivative-security holdings.
Moderna Share and Derivative Records
The direct-share record showed ownership of 87,044 shares following the option exercise. A separate entry recorded the forfeiture of 5,704 shares at $148.87 per share, after which reported ownership stood at 81,340 shares. The derivative-security record showed 106,179 securities following the option exercise. The records associate both transactions with September 4, 2026.
FAQs
Q: What did Moderna Chief Legal Officer Klinger Shannon Thyme do?
A: Klinger Shannon Thyme exercised options for 11,797 Moderna shares on September 4, 2026. The records also show a separate forfeiture of 5,704 shares.
Q: How many Moderna shares did Klinger Shannon Thyme own afterward?
A: Reported ownership was 87,044 shares after the option exercise and 81,340 shares after the separate forfeiture entry at $148.87 per share.
Q: How many derivative securities were reported?
A: Klinger Shannon Thyme held 106,179 Moderna derivative securities after the option exercise. The transaction was recorded under SEC code M.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.